Life sciences and health technology

Expertise in healthcare regulatory rules and intellectual property rights

Bull's team for life sciences and health technology consists of renowned lawyers with extensive industry knowledge. We possess highly specialized expertise in health regulatory rules, intellectual property rights, and other legal areas critical to players in this sector.

Our clients include companies in pharmaceuticals, biotechnology, medtech, and health technology, manufacturers of medical equipment, healthcare organizations, food and dietary supplement producers, public institutions, research environments, investors and acquirers.

Through memberships in Norway Health Tech, ALEAP, and The Life Sciences Cluster, we stay updated on industry trends and developments and actively contribute to knowledge sharing. Our lawyers also regularly provide expert commentary on Norwegian law in various international Life Sciences publications, including:

• Immaterialretten i et nøtteskall, 2nd edition (2021), Gyldendal, co-author
• The International Comparative Legal Guide to Drug & Medical Device Litigation Laws and Regulations (2021 and 2022), co-author
• Pharmaceutical Advertising Laws and Regulations (2019 and 2020), chapter on Norway, ICLG, co-author
• The Life Sciences Law Review, 7th Edition (2018), Norway, co-author
• IAM Patents in Europe 2013/2014 (2013), co-author

Our services include, among other things: